Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The medical impact of hepatitis D virus infection in Uzbekistan
Malika Khodjaeva, Nargiz Ibadullaeva, Aziza Khikmatullaeva, et al.
Liver International (2019) Vol. 39, Iss. 11, pp. 2077-2081
Closed Access | Times Cited: 23

Showing 23 citing articles:

The changing context of hepatitis D
Mario Rizzetto, Saeed Hamid, F. Negro
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1200-1211
Open Access | Times Cited: 126
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
Wenshi Wang, Florian A. Lempp, Franziska Schlund, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 311-323
Open Access | Times Cited: 43
A Review of HDV Infection
Gian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
Viruses (2022) Vol. 14, Iss. 8, pp. 1749-1749
Open Access | Times Cited: 36
New epidemiology of hepatitis delta
Jiannis Vlachogiannakos, George Papatheodoridis
Liver International (2020) Vol. 40, Iss. S1, pp. 48-53
Open Access | Times Cited: 41
Viral hepatitis elimination challenges in low‐ and middle‐income countries—Uzbekistan Hepatitis Elimination Program (UHEP)
Erkin Musabaev, Chris Estes, Shakhlo Sadirova, et al.
Liver International (2023) Vol. 43, Iss. 4, pp. 773-784
Open Access | Times Cited: 13
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis
Mathias Jachs, Teresa Binter, Caroline Schmidbauer, et al.
United European Gastroenterology Journal (2021) Vol. 9, Iss. 10, pp. 1119-1127
Open Access | Times Cited: 27
HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
Imme Roggenbach, Xiumei Chi, Florian A. Lempp, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1799-1799
Open Access | Times Cited: 23
Elimination of HDV: Epidemiologic implications and public health perspectives
Areeba Tharwani, Saeed Hamid
Liver International (2023) Vol. 43, Iss. S1, pp. 101-107
Closed Access | Times Cited: 7
The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal
Mario Rizzetto, Saeed Hamid
Liver International (2020) Vol. 41, Iss. 1, pp. 16-19
Closed Access | Times Cited: 15
Hepatitis delta: Epidemiology to recent advances in therapeutic agents
Nehna Abdul Majeed, Benno Zehnder, Christopher Koh, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1306-1321
Closed Access | Times Cited: 4
Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination
О. В. Исаева, K. K. Kyuregyan, А. А. Карлсен, et al.
Journal of Viral Hepatitis (2022) Vol. 30, Iss. 3, pp. 182-194
Open Access | Times Cited: 4
The distinct spatiotemporal evolutionary landscape of HBV and HDV largely determines the unique epidemic features of HDV globally
Yibo Ding, Hongbo Guo, Xinfang Hong, et al.
Molecular Phylogenetics and Evolution (2024) Vol. 197, pp. 108114-108114
Closed Access
Years of potential life lost due to hepatitis B with or without Delta agent in the Kyrgyz Republic
К. А. Ногойбаева, С. Т. Тобокалова, E. K. Boronbaeva
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 2, pp. 331-338
Open Access
Hepatitis D virus in Uzbekistan
Malika Khodjaeva, Nargiz Ibadullaeva, Aziza Khikmatullaeva, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 3, pp. 238-240
Closed Access | Times Cited: 3
Epidemiology, presentation, and therapeutic approaches for hepatitis D infections
Hanna Blaney, Mian Khalid, Theo Heller, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 21, Iss. 2, pp. 127-142
Open Access | Times Cited: 2
Characterization of the Full-Length Genome Sequences and Phylogenetic Analysis of HDV Strains Isolated from Patients with Chronic HBV and HDV Infection in Kyrgyz Republic
Yu. V. Ostankova, K. A. Nogoybaeva, Е. Б. Зуева, et al.
Problems of Particularly Dangerous Infections (2020), Iss. 1, pp. 124-132
Open Access | Times Cited: 2
Investment in the tourism sector: The pandemic and its impact
Safaeva Sayyora Rikhsibaevna, Matkabulova Dilorom Xalilullaevna, Ochilova Hilola Farmonovna
South Asian Journal of Marketing & Management Research (2020) Vol. 10, Iss. 6, pp. 23-23
Closed Access | Times Cited: 2
The heavy burden of hepatitis D in Uzbekistan
Francesco Negro
Liver International (2019) Vol. 39, Iss. 11, pp. 2034-2035
Open Access | Times Cited: 1
Epidemiology of the Hepatitis D virus
Mario Rizzetto
WikiJournal of Medicine (2020) Vol. 7, Iss. 1, pp. 1-1
Open Access | Times Cited: 1
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?
Zoë Post, Nancy Reau
Clinics in Liver Disease (2023) Vol. 27, Iss. 4, pp. 973-984
Closed Access
Epidemiology of the Hepatitis D virus
Mario Rizzetto
WikiJournal of Medicine (2020) Vol. 7, Iss. 1
Open Access
The prevalence of viral hepatitis D in the world
В. Г. Акимкин, Жанна Понежева, Х.Г. Омарова, et al.
Epidemiology and Vaccinal Prevention (2022) Vol. 21, Iss. 3, pp. 90-95
Open Access
IL28B genetic polymorphism in chronic viral hepatitis
M.A. Abdukadirova, A.S. Khikmatullaeva, Nargiz Ibadullaeva, et al.
Infectious diseases News Opinions Training (2022) Vol. 11, Iss. 2, pp. 64-68
Open Access
Page 1

Scroll to top